Marissa Ceresnie
Dallas, TXNPI 1417585068
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $15,976 of the $19,887 with a category attached, or 80.3%. It is spread thinly across 32 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations.
Across 280 payments — averaging $71.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Incyte Corporation$2K
- Sanofi$2K
- Janssen Scientific Affairs, LLC$2K
- Novartis$1K
- Lilly USA, LLC$897
- plus $8K from 26 others
What the payments were for
- Consulting fees$2,63313%
- Travel & lodging$1,0165%
- Food & beverage$15,97680%
- Education$2621%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 59 | $3,530 |
| Incyte Corporation | 14 | $2,400 |
| Sanofi | 32 | $2,197 |
| Janssen Scientific Affairs, LLC | 11 | $2,076 |
| Novartis | 17 | $1,053 |
| Lilly USA, LLC | 12 | $897 |
| Johnson & Johnson | 21 | $852 |
| Almirall LLC | 13 | $794 |
| Arcutis Biotherapeutics, Inc. | 16 | $732 |
| Pfizer | 16 | $637 |
| Galderma Laboratories, L.p. | 8 | $575 |
| UCB, Inc. | 6 | $568 |
| Sun Pharmaceutical Industries Inc. | 11 | $465 |
| E.r. Squibb & Sons, L.L.C. | 6 | $453 |
| Boehringer Ingelheim | 6 | $424 |
| Kyowa Kirin, Inc. | 4 | $258 |
| Amgen | 3 | $224 |
| Blueprint Medicines Corporation | 2 | $210 |
| Dermavant Sciences, Inc. | 2 | $205 |
| Regeneron Healthcare Solutions, Inc. | 4 | $202 |
| Organon | 2 | $199 |
| Merz North America, Inc. | 1 | $194 |
| Sandoz | 2 | $129 |
| Genentech USA, Inc. | 1 | $128 |
| Stemline Therapeutics Inc. | 1 | $117 |
| Boston Scientific | 1 | $114 |
| Journey Medical Corporation | 2 | $112 |
| Mayne Pharma Commercial LLC | 3 | $58 |
| Biofrontera Inc. | 1 | $22 |
| Chiesi USA, Inc. | 1 | $22 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $21 |
| Botanix SB Inc | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.